세계 문합기 시장 규모는 예측 기간인 2024-2031년 5.85%의 CAGR로 2023년 40억 1,000만 달러에서 2031년 63억 1,000만 달러로 성장할 것으로 예상됩니다. 이 시장은 최근 몇 년 동안 괄목할 만한 성장세를 보였으며, 앞으로도 견조한 성장세를 유지할 것으로 예상됩니다. 문합기는 수술 부위에서 혈관, 장 및 조직 연결을 용이하게함으로써 첨단 수술에서 중요한 역할을 합니다. 이러한 기구는 정확하고 효과적인 문합을 보장하여 최상의 결과와 빠른 치유 시간을 가능하게 합니다. 문합기에는 다양한 종류가 있으며, 수술의 종류에 따라 사용됩니다.
문합기 시장은 수술 부담 증가 등 여러 요인에 의해 성장하고 있습니다. 인구 증가, 특히 질병에 취약한 노령 인구의 증가는 봉합사와 같은 문합기의 필요성을 요구하는 외과 수술의 증가로 이어지고 있습니다. 많은 사람들이 앉아서 생활하기 때문에 심혈관 질환, 소화기 질환 등 수술로 치료하고 봉합이 필요한 많은 질병이 발생하고 있습니다.
시장에는 고품질의 고급 수술을 지원하는 첨단 기술을 제공하는 기업들도 있습니다. 제약회사들은 문합기 연구개발에 많은 투자를함으로써 이 과정에 혁명을 일으키려고 노력하고 있습니다.
이 보고서는 세계 문합기 시장을 조사하여 시장 개요와 함께 제품 유형별, 응용 유형별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.
Global anastomosis devices market is projected to witness a CAGR of 5.85% during the forecast period 2024-2031, growing from USD 4.01 billion in 2023 to USD 6.31 billion in 2031. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years. Anastomosis devices play an important role in advanced surgical procedures, by facilitating the connection of blood vessels, intestines, and tissues at the surgical sites. These devices ensure precise and effective anastomosis, enabling best outcomes and a reduction in healing time. There are various types of anastomosis devices which are used depending on the type of surgery that has been done.
The anastomosis devices market is witnessing growth, which is driven by many factors, most prominent being the rising burden of surgical procedures. Rising population, especially the geriatric population, which is more prone to diseases is leading to an increase in surgical procedures which demands the need for anastomosis devices such as sutures. The sedentary lifestyle of many people has led to many diseases such as cardiovascular diseases, gastrointestinal diseases, and many others which are treated with surgery and require suturing.
Several players in the market are bringing advanced technologies that support high-quality and advanced surgical procedures. Pharmaceutical companies are coming together to revolutionize the process by heavily investing in the R&D of anastomosis devices. For instance, Serger Surgical Solutions commenced the development of the next-generation laparoscopic bowel closure device for intracorporeal anastomosis in January 2022. This new device is called LAP IA 60 and is capable of closing and aligning common opening for intracorporeal anastomosis.
Rising Demand for Surgical Procedures
Rise in prevalence of chronic and acute diseases is directly impacting the rise in surgical procedures. As the global population grows, the number of diseases which cause increase in the number of surgical procedures. There are many medical conditions that need to be treated surgically as well as need special attention. For instance, in January 2022, the British Heart Foundation published in a report about the waiting lists for heart surgeries that is increasing with time. There are 280,000 people who are waiting for heart surgeries which is approximately 22% higher than the number of heart patients that were there before the pandemic. This surging rate of patients waiting for surgery is a clear sign of rising burden in surgical procedures which eventually increases the demand of anastomosis devices. Surgical sutures and staplers are required in such procedures as they are the conventional methods used in any surgical procedures and are trusted by healthcare professionals. Further rising geriatric population which is more prone to different medical conditions is an indicator of the rising need for surgical procedures. According to projections made by the world population prospectus in 2022, the share of geriatric population will go from 10% in 2022 to 16% in 2050.
Technological Advancements Catalyzes the Market Growth
Technological advancements in the anastomosis market are a foundation of growth and expansion in the market, promoting innovation and reshaping surgical practices. Advancements have steered in a new era of precision, efficiency, and safety in surgical anastomosis procedures, contributing prominently to expanding the market. One of the key drivers in the market is the growing popularity of minimally invasive methods of surgery which does require less sutures.
Advanced techniques such as laparoscopic and robot assisted procedures have gained traction leading to rise in the anastomosis devices market. These techniques require smaller incisions, reduced trauma to the surrounding tissues and reduced recovery time in comparison to traditional open surgeries. This has resulted in increased demand for advanced anastomosis devices that are compatible with minimally invasive procedures, further pushing the market growth. Newly developed anastomosis devices have real time monitoring and feedback capabilities during surgery.
For instance, the development of robotic surgical staplers that are fitted with software can ensure more uniformity in the suture and increase the efficacy and ease of usage while eliminating the chances of human error. Such devices enable surgeons to make data-driven decisions and optimize procedural outcomes, leading to more patient centric care. As medical professionals focus more on patient centric and value-based approaches, demand for technologically advanced devices is expected to continue to grow more. Hence, technological advancements serve as important and powerful factors in the expansion of the anastomosis devices market.
Dominance of Surgical Sutures
While anastomosis devices are used to make connection between blood vessels, organs and tissues surgical sutures enhance it by providing additional support to the conjunction and reinforce the connection to promote faster healing. Surgical sutures are the most convenient and traditionally used sutures that may be absorbable or non-absorbable depending on the site of surgery. The advancements made in suturing techniques and materials contribute to the growth of anastomosis devices market. Absorbable sutures gradually dissolve over time which eliminate the need to remove them. There are sutures available in the market which have an antimicrobial coating over them which helps minimize the risk of any infections at the surgical site. Such advances provide more efficiency and reduction in the healing time and devise a more patient friendly approach which leads to increased demand.
For instance, Johnson & Johnson MedTech published in 2023, about their Stratafix Sutures getting recognition for achieving great milestones in healthcare. These sutures are now widely accepted in healthcare sector for a variety of surgical procedures. As healthcare professionals seek to minimize post-operative complications and reduce healthcare costs, there is growing interest in integrated solutions that can streamline surgical workflows and improve efficiency. The integration of anastomosis devices with surgical sutures has the ability to provide the utmost care and efficiency facilitating smoother procedures and outcomes.
North America to Dominate Anastomosis Devices Market
North America is anticipated to have a significant market share over the forecast period in the anastomosis device market. Due to the rising burden of chronic diseases and population in North America, healthcare related engagement is increasing, which encourages a rise in surgical procedures. North America is experiencing a significant increase in different diseases that need to be treated surgically and need more attention. About 2.4 million Canadians have a heart disease according to a report by Canadian Institute for Health Information updated in June 2022. In addition, according to a report by Spotlight on Heart failure published in 2022, more than 0.1 million Canadians are likely to be diagnosed with heart failure each year. As per the above-mentioned statistics, a surge in heart-related diseases is expected in the forecast period. North America, being a hub of healthcare giants that provide the best possible cutting-edge technology, is prone to rise in burden of surgical procedures and advanced treatments that require anastomosis devices, leading to expansion of this market.
Future Market Scenario (2024 - 2031F)
Presence of various chronic diseases that occur and re-occur and need surgical treatment are the biggest reason behind the growth of anastomosis devices market. Rising geriatric population that is prone to fatal diseases is increasing the burden of surgical procedures. Technological advancements are the leading the way of advanced surgical procedures. Companies in this industry are collaborating to make a global presence as well as to manufacture revolutionary healthcare solutions. For instance, Ethicon, a part of Johnson & Johnson in June 2022, launched the ECHELON 3000 stapler, a device that is digitally enabled and provides surgeons with simple, one-handed powered articulation to help them
Key Players Landscape and Outlook
Several companies are expanding business by planning and adopting new strategies. They are adopting new strategic initiatives regarding various anastomosis devices to increase their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, and investments and partnerships are a few ways through companies are aiming to increase their global presence.
Lydus Medical in January 2023 announced that the Vesseal received regulatory 510(k) approval from FDA. The Vesseal is a microvascular anastomosis suture deployment system for standardized omni-vessel anastomoses, enabling simple, fast, safe, and effective procedures.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.